Revelation Pharma Acquires Acacia Apothecary to Enhance Compounding Pharmacy Services

Revelation Pharma Expands Horizons with Acacia Apothecary Acquisition

In a significant development within the pharmaceutical compounding sector, Revelation Pharma has acquired Acacia Apothecary & Wellness, a respected compounding pharmacy located in Tucson, Arizona. This acquisition, announced on October 9, 2025, marks a strategic move by Revelation Pharma to enhance its expertise in critical areas such as hormone therapy, women's health, and personalized medicine. With a strong foundation established by founders Justin and Heather Brock in 2014, Acacia Apothecary is known for its patient-centered approach and high-quality formulations that cater to both human and veterinary medicine.

The integration of Acacia Apothecary will not only expand Revelation's operational footprint but also bolster its commitment to delivering exceptional patient care. Justin Brock, PharmD, will transition to Revelation Pharma as an Operational Consultant, bringing his extensive knowledge and recognition as a Fellow of the Alliance for Pharmacy Compounding (APC). His addition to the team is anticipated to deepen Revelation’s influence in the pharmacy industry, enabling the company to leverage Acacia’s established reputation and expertise in personalized medication. Shawn Hodges, CEO of Revelation Pharma, conveys enthusiasm for the merger, emphasizing a shared mission of advocacy and innovation in pharmacy services.

This acquisition underscores Revelation Pharma's ongoing strategy to create a national network of top-tier compounding pharmacies. By integrating Acacia Apothecary's services, Revelation Pharma aims to strengthen its offerings in areas such as pain management, dermatology, and hormone therapy, thereby enhancing the overall pharmacy landscape in Tucson and beyond. The merger is not only a triumph for Revelation but also a promising opportunity for the Tucson community, which will benefit from expanded compounding services tailored to individual patient needs.

In light of this acquisition, Revelation Pharma is poised to reinforce its leadership in the compounding pharmacy sector, focusing on education, advocacy, and innovation. By combining resources and expertise, the company aims to elevate the standards of personalized medicine and cater to a broader patient demographic. Those interested in learning more about the merger and Revelation Pharma’s offerings can visit their website for additional information.